Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

360 ARTÍCULOS , VIENDO DEL 121 AL 135

A pilot usability study of MINWii, a music therapy game for demented patients

Boulay M, Benveniste S, Boespflug S, Jouvelot P, Rigaud AS.

Technol Health Care. 2011;19(4):233-46. doi: 10.3233/THC-2011-0628.

New drugs for Alzheimer's disease in Japan

Takeda M, Tanaka T, Okochi M.

Psychiatry Clin Neurosci. 2011 Aug;65(5):399-404. doi: 10.1111/j.1440-1819.2011.02253.x.

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Karran E, Mercken M, De Strooper B.

Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712. doi: 10.1038/nrd3505.

Alzheimer's disease: emerging trends in small molecule therapies

Mohamed T, Rao PP.

Curr Med Chem. 2011;18(28):4299-320. doi: 10.2174/092986711797200435.

Role of serotonin in Alzheimer's disease: a new therapeutic target?

Geldenhuys WJ, Van der Schyf CJ.

CNS Drugs. 2011 Sep 1;25(9):765-81. doi: 10.2165/11590190-000000000-00000.

Effects of gender on burden among caregivers of Alzheimer's patients

Akpınar B, Küçükgüçlü O, Yener G.

J Nurs Scholarsh. 2011 Sep;43(3):248-54. doi: 10.1111/j.1547-5069.2011.01402.x. Epub 2011 Jul 18.

[Dementia: progress in diagnosis and treatment; editorial, towards the preclinical treatment of Alzheimer disease]

Iwatsubo T.

Nihon Naika Gakkai Zasshi. 2011 Aug 10;100(8):2089-91. doi: 10.2169/naika.100.2089.

[Pharmacological and clinical profiles of galantamine (Reminyl(®))]

Nagino K, Shikinami K, Saito T, Harada Y.

Nihon Yakurigaku Zasshi. 2011 Sep;138(3):122-6. doi: 10.1254/fpj.138.122.

Chronic divalproex sodium use and brain atrophy in Alzheimer disease

Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c. Epub 2011 Sep 14.

[Current trend of immunotherapy for Alzheimer's disease]

Matsumoto SE, Tabira T.

Nihon Rinsho. 2011 Sep;69(9):1628-32.

Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine

Anekonda TS, Quinn JF.

Biochim Biophys Acta. 2011 Dec;1812(12):1584-90. doi: 10.1016/j.bbadis.2011.08.013. Epub 2011 Sep 8.

Therapeutic compliance of nanomedicine in Alzheimer's disease

Wilson B.

Nanomedicine (Lond). 2011 Sep;6(7):1137-9. doi: 10.2217/nnm.11.114.

Antioxidant pathways in Alzheimer's disease: possibilities of intervention

Viña J, Lloret A, Giraldo E, Badia MC, Alonso MD.

Curr Pharm Des. 2011 Dec;17(35):3861-4. doi: 10.2174/138161211798357755.

A randomized controlled trial of an activity specific exercise program for individuals with Alzheimer disease in long-term care settings

Roach KE, Tappen RM, Kirk-Sanchez N, Williams CL, Loewenstein D.

J Geriatr Phys Ther. 2011 Apr-Jun;34(2):50-6. doi: 10.1519/JPT.0b013e31820aab9c.

Use of memantine for the treatment of dementia

Lo D, Grossberg GT.

Expert Rev Neurother. 2011 Oct;11(10):1359-70. doi: 10.1586/ern.11.132.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias